JS Link, Inc. (KOSDAQ:127120)
32,950
+100 (0.30%)
At close: Jun 12, 2026
JS Link Revenue
JS Link had revenue of 2.42B KRW in the quarter ending March 31, 2026, with 69.40% growth. This brings the company's revenue in the last twelve months to 20.31B, up 42.28% year-over-year. In the year 2025, JS Link had annual revenue of 19.32B with 21.43% growth.
Revenue (ttm)
20.31B
Revenue Growth
+42.28%
P/S Ratio
56.18
Revenue / Employee
241.75M
Employees
84
Market Cap
1.14T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 19.32B | 3.41B | 21.43% |
| Dec 31, 2024 | 15.91B | -6.04B | -27.52% |
| Dec 31, 2023 | 21.95B | 4.97B | 29.26% |
| Dec 31, 2022 | 16.98B | -6.01B | -26.14% |
| Dec 31, 2021 | 22.99B | 7.71B | 50.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HansBiomed | 110.50B |
| Aimed Bio | 54.20B |
| ROKIT Healthcare | 30.61B |
| S.Biomedics | 16.48B |
| Qurient | 7.00B |
| Inventage Lab | 3.16B |
| IntoCell | 2.47B |
| AprilBio | 725.35M |